Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update Second quarter revenue of $18.8 million Completed $250 million. | August 8, 2022
86 Read
DKSH Business Unit Technology has entered into an exclusive partnership with Nicoya, an innovative manufacturer of SPR instruments, headquartered in Kitchener, Canada. DKSH will provide marketing, sales and after-sales services support in selected markets across Asia, including Indonesia, Malaysia, Philippines, Taiwan, Thailand, Singapore and Vietnam.
More on This
TAICHUNG, Taiwan DKSH, the Market Expansion Services provider with a focus on Asia held a Studer seminar in Taichung.
Nicoya has developed Alto, the world’s first digital high-throughput benchtop SPR instrument. It is capable of accelerating drug discovery using a fraction of sample volume traditionally required for biomolecular interaction analyses. Alto helps biotechnology and pharmaceutical companies go to market faster with increased efficiency and success early in their product pipelines.